Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis

Proteome Science

Volumn 10, Issue 1, 2012, Pages

  Zhang, Lu ^a   Wang, Qingzhong ^b   Wang, Wenjie ^a   Liu, Yanyan ^a   Wang, Jie ^c   Yue, Jun ^c   Xu, Ying ^a   Xu, Wenxi ^a   Cui, ZhenLing ^c   Zhang, Xuelian ^a   Wang, Honghai ^a  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Daan Centre for Medical Laboratory   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Drug resistance; Immunoproteomics; Mycobacterium tuberculosis; Serodiagnosis

Indexed keywords

ANTIBODY; MYCOBACTERIUM ANTIGEN; RECOMBINANT PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG RESISTANT TUBERCULOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84862808880     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-10-12     Document Type: Article

References (37)

1. WHO Guidelines for surveillance of drug resistance in tuberculosis (document WHO/HTM/TB/2009.422). 2009, Geneva: World Health Organization, WHO.
2. WHO Anti-tuberculosis drug resistance in the world. Third global report. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance(WHO/CDC/TB/2004). 2004, Geneva: World Health Organization, WHO.
3. Dorman SE, Chaisson RE. From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nat Med 2007, 13:295-298. 10.1038/nm0307-295, 17342143.
4. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CFJ, Krishna S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021. 10.1016/S0140-6736(06)69342-2, 16980117.
5. Marris E. From TB tests, just a 'yes or no' answer, please. Nat Med 2007, 13:267. 10.1038/nm0307-267, 17342123.
6. Lyashchenko KR, Colangele M, Houde HA, Jahadali D, Menizies GML. Heterogenous antibody responses in tuberculosis. Infect Immun 1998, 66:3936-3940. 108457, 9673283.
7. Abebe F, Holm-Hansen C, Wiker HG, Bjune G. Progress in Serodiagnosis of Mycobacterium tuberculosisInfection. Scand J Immunol 2007, 66:176-191. 10.1111/j.1365-3083.2007.01978.x, 17635795.
8. Starck J, Kallenius G, Marklund BI, Andersson DI, Akerlund T. Comparative proteome analysis of Mycobacterium tuberculosi grown under aerobic and anaerobic conditions. Microbiol 2004, 50:821-3829.
9. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosi persistence by gene and protein expression profiling. Mol Microbiol 2002, 43:717-731. 10.1046/j.1365-2958.2002.02779.x, 11929527.
10. Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, Halada P, Lamer S, Kaufmann SHE. Comparative proteome analysis of Mycobacterium tuberculosi and Mycobacterium bovi BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999, 33:1103-1117.
11. Mattow J, Jungblut PR, Schaible UE, Mollenkopf HJ, Lamer S, Zimny-Arndt U, Hagens K, Müller EC, Kaufmann SHE. Identification of proteins from Mycobacterium tuberculosi missing in attenuated Mycobacterium bovi BCG strains. Electrophoresis 2001, 22:2936-2946. 10.1002/1522-2683(200108)22:14<2936::AID-ELPS2936>3.0.CO;2-S, 11565788.
12. Mawuenyega KG, Forst CV, Dobos KM, Belisle JT, Chen J, Bradbury EM, Bradbury ARM, Chen X. Mycobacterium tuberculosis Functional Network Analysis by Global Subcellular Protein Profiling. Mol Biol Cell 2005, 16:396-404. 539182, 15525680.
13. Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, Brestrich G, Haeselbarth G, Müller EC, Jungblut PR, Kaufmann SHE. Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M-bovi BCG Copenhagen. Electrophoresis 2003, 24:3405-3420. 10.1002/elps.200305601, 14595687.
14. Pheiffer C, Betts JC, Flynn HR, Lukey PT, van Helden P. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 2005, 151:1139-1150. 10.1099/mic.0.27518-0, 15817781.
15. Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, Krah A, Schmidt F, Jungblut PR, Kaufmann SHE, Schaible UE. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 2006, 6:2485-2494. 10.1002/pmic.200500547, 16548060.
16. Sanchez-Campillo M, Bini L, Comanducci M, Raggiaschi R, Marzocchi B, Pallini V, Ratti G. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 1999, 20:2269-2279. 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D, 10493131.
17. Jungblut PR. Proteome analysis of bacterial pathogens. Microbes Infect 2001, 3:831-840. 10.1016/S1286-4579(01)01441-1, 11580978.
18. Tjalsma H, Schaeps MJR, Swinkels WD. Immunoproteomics: From biomarker discovery to diagnostic applications. Proteomics Clin 2008, 2:167-180.
19. Bassey EOE, Catty D, Kumararatne DS, Raykundalia C. Candidate antigens for improved serodiagnosis of tuberculosis. Tuber Lung Dis 1996, 77:136-145. 10.1016/S0962-8479(96)90028-3, 8762848.
20. Samanich KM, Belisle JT, Sonnenberg MG, Keen MA, Zolla-Pazner S, Laal S. Delineation of Human Antibody Responses to Culture Filtrate Antigens of Mycobacterium tuberculosis. J Infect Dis 1998, 178:534-1538.
21. Charlet D, Mostowy S, Alexander D, Sit L, Wiker HG, Behr MA. Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol Microbiol 2005, 56:1302-1313. 10.1111/j.1365-2958.2005.04618.x, 15882422.
22. Saïd-Salim B, Mostowy S, Kristof AS, Behr MA. Mutations in Mycobacterium tuberculosis Rv0444c, the gene encoding anti-SigK, explain high level expression of MPB70 and MPB83 in Mycobacterium bovis. Mol Microbiol 2006, 62:1251-1263. 10.1111/j.1365-2958.2006.05455.x, 17064366.
23. Preneta R, Papavinasasundaram KG, Cozzone AJ, Duclos B. Autophosphorylation of the 16 kDa and 70 kDa antigens (Hsp 16.3 and Hsp 70) of Mycobacterium tuberculosis. Microbiol 2004, 150:2135-2141.
24. Beck ST, Leite OM, Arruda RS, Ferreira AW. Humoral response to low molecular weight antigens of Mycobacterium tuberculosis by tuberculosis patients and contacts. Braz J Med Biol Res 2005, 38:587-596. 10.1590/S0100-879X2005000400013, 15962185.
25. Demissie A, Leyten EM, Abebe M. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol 2006, 13:179-186. 10.1128/CVI.13.2.179-186.2006, 1391929, 16467323.
26. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132. 10.1016/0022-2836(82)90515-0, 7108955.
27. Zhang M, Yang YP, Xu Y, Qie YQ, Wang JL, Zhu BD, Wang QZ, Jin RL, Xu SF, Wang HH. Trehalose-6-phosphate Phosphatase from Myco bacterium tuberculosis induces humoral and cellular immuneresponses. FEMS Immunol Med Microbiol 2007, 49:68-74. 10.1111/j.1574-695X.2006.00174.x, 17266712.
28. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 75(9729):1920-1937.
29. Shreemanta KP, Kaufmann SHE. The quest for biomarkers in tuberculosis. Drug Discov Today 2010, 15(3/4):148-157.
30. Pedersen SK, Sloane AJ, Prasad SS, Sebastian LT, Lindner RA, Hsu M, Robinson M, Bye PT, Weinberger RP, Harry JL. An Immunoproteomic approach for identification of clinical biomarkers for monitoring disease. Mol Cell Proteomics 2005, 4:1052-1060. 10.1074/mcp.M400175-MCP200, 15901828.
31. Leroy B, Roupie V, Noel-Georis I, Rosseels V, Walravens K, Govaerts M, Huygen K, Wattiez R. Antigen discovery, A postgenomic approach to paratuberculosis diagnosis. Proteomics 2007, 7:1164-1176. 10.1002/pmic.200600988, 17366477.
32. Ramaswamy SV, Reich R, Dou SJ, Jasperse L, Pan X, Wanger A, Quitugua T, Graviss EA. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Ch 2003, 47:1241-1250.
33. Bahk YY, Kim SA, Kim JS, Euh YJ, Bai GH, Cho SN, Kim YS. Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker. Proteomics 2004, 4:1-9. 10.1002/pmic.200300503, 14730666.
34. Zheng XJ, Hong LL, Shi LX, Guo JQ, Sun Z, Zhou JY. Proteomic analysis of host cells infected with infectious bursal disease virus. Mol Cell Proteomics 2008, 7:612-625.
35. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605. 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6, 10217175.
36. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002, 1:323-333. 10.1074/mcp.M200001-MCP200, 12096114.
37. Sambrook J, Fritsch EF, Maniatis T. Molecular Coning: A Laboratory Manual 1989, New York: Cold Spring Harbor Laboratory Press, 2.